Evaluation and management of pituitary-adrenal function after pituitary surgery

Endocrinologist

Volumn 9, Issue 1, 1999, Pages 16-24

  Hamrahian, Amir H ^a   El Mallawany, Nader K ^a   Arafah, Baha M ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CORTICOTROPIN;

CORTICOTROPIN BLOOD LEVEL; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; ENDOCRINE SURGERY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPHYSIS FUNCTION; HYPOTHALAMUS HYPOPHYSIS SYSTEM; POSTOPERATIVE PERIOD; REVIEW; SURGICAL APPROACH;

EID: 0032975933     PISSN: 10512144     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019616-199901000-00005     Document Type: Review

References (15)

1. Klibansld A, Zervas NT: Diagnosis and management of hormone secreting pituitary adenomas. N Engl J Med 1991; 324: 822-31.
2. Arafah BM: Reversible hypopituitarism in patients with large nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 1986; 62: 1173-9.
3. Hout WM, Arafah BM, Salazar R, Selman W: Evaluation ofhypothalamic-pituitary-adrenal axis immediately after pituitary adenomectomy: is peri-operative steroid therapy necessary? J Clin Endocrinol Metab 1988; 66: 1208-12.
4. Arafah B, Kailani SH, Nekl KE, Gold RS, Selman WR: Immediate recovery of pituitary function after transsphenoidal resection of pituitary macroadenomas. J Clin Endocrinol Metab 1994; 79:348-54.
5. Garcia-Luna PP, Leal-Cerro A: Evaluation of the pituitary-adrenal axis before, during and after pituitary adenomectomy. Is peri-operative glucocorticoid therapy necessary? Acta Endocrinol 1990; 122: 83-8.
6. Auchus RJ, Shewbridge RK, Shepherd MD: Which patients benefit from provocative adrenal testing after transsphenoidal pituitary surgery? Clin Endocrinol 1997; 46: 21-7.
7. Tordjman K, Jaffe A, Grazas N: The role of the low dose (1 ug) adrenocorticotropin test in the evaluation of patients with pituitary diseases. J Clin Endocrinol Metab 1995; 80: 1301-5.
8. Arafah BM, Ybarra J, Madhun Z, Hamrahian A: Discordant results between insulin-induced hypoglycemia (IIH), the low dose (LDC, 1 μ,g), and the standard dose (SDC, 250 μ,g) cortrosyn stimulation tests in patients with pituitary tumors: improved specificity of LDC by increasing the cortisol cutoff for normal response and measurements of DHEA-S. Endocrine Society Meeting Abstract, New Orleans, LA, June 1998; Abstract No. OR 12-4.
9. Mukherjee JJ, Jacome de Castro J, Kaltsas G: A comparison of the insulin tolerance/glucagon test with the short ACTH stimulation test in the assessment of the hypothalamo-pituitary-adrenal axis in the early post-operative period after hypophysectomy. Clin Endocrinol 1997; 47: 51-60.
10. Vance ML: Hypopituitarism. N Engl J Med 1994; 330: 1651-62.
11. Lamberts SWJ, Bruining HA, DE Jong FH: Corticosteroids therapy in severe illness. N Engl J Med 1997; 337: 1285-92.
12. Graham KE, Samuels MH, Raff H: Intra-operative adrenocorticotropin levels during transsphenoidal surgery for Cushing's disease do not predict cure. J Clin Endocrinol Metab 1997; 82: 1776-9.
13. McCance DR, Besser M, Atkinson AB: Assessment of cure after transsphenoidal surgery for Cushing's disease. Clin Endocrinol 1996; 44: 1-6.
14. Arafah BM, Pearson OH: Cushing's syndrome. In Conn's Current Therapy, 36th Edition, edited by Rakel ED, pp. 472-7, Philadelphia, WB Saunders Company 1984.
15. Arafah BM, Ybarra J, Madhun ZT, Selman WR: Pituitary tumor apoplexy: pathophysiology, clinical manifestations and management. J Intensive Care Med 1997; 12: 123-34.